Patients should disclose all medical conditions and medications
The Precision Peptide Genetic Test examines 14 metabolic pathways and 49 peptides to optimize your medication response, but it does not specifically predict thyroid nodule formation
The V5 platform was based on the Illumina Global Screening Array, consisting of approximately 654,000 preselected SNPs and approximately 50,000 custom content variants

Peptides May Be Preferred When: You want to preserve natural testosterone production and HPG axis function Fertility is a current or future concern Testosterone levels are mildly to moderately low (300-500 ng/dL) Symptoms are present but not severely impacting quality of life You prefer a therapy that works with your bodys natural systems You are interested in the additional benefits of GH optimization alongside testosterone support TRT May Be Preferred When: Testosterone levels are severely low (below 250 ng/dL) Symptoms are significantly impacting daily function and quality of life Primary hypogonadism (testicular failure) is the diagnosis, where the testes cannot respond to stimulation Faster and more predictable results from testosterone therapy are clinically important Previous peptide therapy has not produced adequate improvement In some cases, a combined approach using both peptides and TRT may be optimal

It works well on its own or when combined with other skincare ingredients that support skin health
Current Cardiology Reviews, 6 , 337342